Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04107740
Recruitment Status : Unknown
Verified September 2019 by HLB Pharmaceutical Co., Ltd..
Recruitment status was:  Recruiting
First Posted : September 27, 2019
Last Update Posted : October 2, 2019
Sponsor:
Information provided by (Responsible Party):
HLB Pharmaceutical Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : June 2020